目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
1.10.4 Objective - 4

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Preclinical CRO Market: Variables, Trends, & Scope
3.1 Segment Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.3 Rising R&D offshoring
3.3.1 Rising outsourcing trend
3.3.2 Life sciences companies focusing on their core competencies
3.3.2 Market Restraint Analysis
3.3.2.1 Monitoring issues and lack of standardization
3.4 Preclinical CRO Market Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Industry Analysis Porter’s
3.4.2.1 Competitor rivalry (High)
3.4.2.2 Bargaining power of buyers(high)
3.4.2.3 Bargaining power of suppliers(Low)
3.4.2.4 Threat of substitutes (low)
3.4.2.5 Threat of new entrants (Low)
3.4.3 PESTEL Analysis
3.4.3.1 PESTLE Analysis
3.4.3.1.1 Political And LegaL
3.4.3.1.1.1 Strengths
3.4.3.1.1.2 Weaknesses
3.4.3.1.1.3 Opportunities
3.4.3.1.1.4 Threats
3.4.3.1.2 Economic
3.4.3.1.2.1 Strengths
3.4.3.1.2.2 Weaknesses
3.4.3.1.2.3 Opportunities
3.4.3.1.2.4 Threats
3.4.3.1.3 Social and Environmental
3.4.3.1.3.1 Strengths
3.4.3.1.3.2 Weaknesses
3.4.3.1.3.3 Opportunities
3.4.3.1.3.4 Threats
3.5 COVID-19 Impact Analysis

Chapter 4 Preclinical CRO Market: Service Segment Analysis
4.1 Definitions & Scope
4.2 Preclinical CRO: Market Service Share Analysis, 2021 & 2030
4.3 Bioanalysis and DMPK Studies
4.3.1 Bioanalysis and DMPK studies market, 2018 - 2030 (USD Million)
4.3.2 In-vitro ADME
4.3.2.1 In-vitro Adme Market, 2018 - 2030 (USD Million)
4.3.3 In-Vivo Pk
4.3.3.1 In-Vivo Pk Market, 2018 - 2030 (USD Million)
4.4 Toxicology Testing
4.4.1 Toxicology Testing Market, 2018 - 2030 (USD Million)
4.4.2 Glp
4.4.2.1 Glp Market, 2018 - 2030 (USD Million)
4.4.3 Non-Glp
4.4.3.1 Non-Glp Market, 2018 - 2030 (USD Million)
4.5 Compound Management
4.5.1 Compound Management Companies market, 2018 - 2030 (USD Million)
4.5.2 Process R&D
4.5.2.1 Process r&D Market, 2018 - 2030 (USD Million)
4.5.3 Custom Synthesis
4.5.3.1 Custom Synthesis Market, 2018 - 2030 (USD Million)
4.5.4 Others
4.5.4.1 Others Market, 2018 - 2030 (USD Million)
4.6 Chemistry
4.6.1 Chemistry Testing Market, 2018 - 2030 (USD Million)
4.6.2 Medicinal Chemistry
4.6.2.1 Medicinal Chemistry Market, 2018 - 2030 (USD Million)
4.6.3 Computation Chemistry
4.6.3.1 Computation Chemistry Market, 2018 - 2030 (USD Million)
4.7 Safety Pharmacology
4.7.1 Safety Pharmacology market, 2018 - 2030 (USD Million)
4.8 Others
4.8.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Preclinical CRO Market: Model Type Segment Analysis
5.1 Definition & Scope
5.2 Preclinical CRO: Market Model Type Share Analysis, 2021 & 2030
5.3 Patient Derived Organoid (PDOs) Models
5.3.1 Patient Derived Organoid (PDOs) Models market, 2018 - 2030 (USD Million)
5.4 Patient Derived Xenograft (PDX) Models
5.4.1 Patient Derived Xenograft (PDX) Models market, 2018 - 2030 (USD Million)

Chapter 6 Preclinical CRO Market: End-use Segment Analysis
6.1 Definitions & Scope
6.2 Preclinical CRO: Market End-use Share Analysis, 2021 & 2030
6.3 Biopharmaceutical Companies
6.3.1 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
6.4 Government and Academic Institutes
6.4.1 Government and Academic Institutes market, 2018 - 2030 (USD Million)
6.5 Medical Device Companies
6.5.1 Medical Device Companies market, 2018 - 2030 (USD Million)

Chapter 7 Preclinical CRO Market: Regional Analysis
7.1 Preclinical CRO: Market Share Analysis, 2021 & 2030
7.2 North America
7.2.1 North America Preclinical CRO market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Preclinical CRO market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada preclinical CRO market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe preclinical CRO market, 2018 - 2030 (USD Million)
7.3.2 UK
7.3.2.1 UK preclinical CRO market, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Preclinical CRO market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France preclinical CRO market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy preclinical CRO market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain preclinical CRO market, 2018 - 2030 (USD Million)
7.3.7 Denmark
7.3.7.1 France preclinical CRO market, 2018 - 2030 (USD Million)
7.3.8 Sweden
7.3.8.1 Italy preclinical CRO market, 2018 - 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Spain preclinical CRO market, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Japan Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.3 China
7.4.3.1 China Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.4 India
7.4.4.1 India Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Australia Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.7 Singapore
7.4.7.1 Singapore Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.8 Philippines
7.4.8.1 Philippines Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.9 Indonesia
7.4.9.1 Indonesia Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.10 Malaysia
7.4.10.1 Malaysia Preclinical CRO Market, 2018 - 2030 (USD Million)
7.4.11 Thailand
7.4.11.1 Thailand Preclinical CRO Market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Preclinical CRO Market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Preclinical CRO Market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Preclinical CRO Market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Preclinical CRO Market, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA Preclinical CRO Market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Preclinical CRO market, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Preclinical CRO market, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Preclinical CRO market, 2018 - 2030 (USD Million)
7.6.5 Kuwait
7.6.5.1 Kuwait Preclinical CRO market, 2018 - 2030 (USD Million)

Chapter 8 Company Profiles
8.1 Company Profiles
8.1.1 WuXi AppTec, Inc. (WAI)
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Service benchmarking
8.1.1.4 Strategic initiatives
8.1.2 LABCORP
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Service benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Eurofins scientific se
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Service benchmarking
8.1.3.4 Strategic initiatives
8.1.4 Medpace holdings inc.
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Service benchmarking
8.1.5 Charles River Laboratories International, Inc.
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Service benchmarking
8.1.5.4 Strategic initiatives
8.1.6 Intertek group plc (igp)
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Service benchmarking
8.1.6.4 Strategic initiatives
8.1.7 SGA SA
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Service benchmarking
8.1.7.4 Strategic initiatives
8.1.8 PPD (THERMO FISHER SCIENTIFIC, INC.)
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Service benchmarking
8.1.8.4 Strategic initiatives
8.1.9 PRA Health Sciences, INC. (ICON plc)
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Service benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 CROwn bioscience
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Service benchmarking
8.1.10.4 Strategic initiatives

Chapter 9 KOL commentary

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Volume price analysis
Fig. 8 Preclinical CRO market snapshot (2021) (USD Million)
Fig. 9 Preclinical CRO market segmentation
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Porter’s five forces analysis
Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 15 Preclinical CRO market service outlook: Segment dashboard
Fig. 16 Preclinical CRO market: Service movement analysis
Fig. 17 Bioanalysis and DMPK studies market, 2018 - 2030 (USD Million)
Fig. 18 In-vitro ADME market, 2018 - 2030 (USD Million)
Fig. 19 In-vivo PK market, 2018 - 2030 (USD Million)
Fig. 20 Toxicology testing market, 2018 - 2030 (USD Million)
Fig. 21 GLP market, 2018 - 2030 (USD Million)
Fig. 22 Non-GLP market, 2018 - 2030 (USD Million)
Fig. 23 Non-mammalian source market, 2018 - 2030 (USD Million)
Fig. 24 Process R&D market, 2018 - 2030 (USD Million)
Fig. 25 Custom synthesis market, 2018 - 2030 (USD Million)
Fig. 26 Others market, 2018 - 2030 (USD Million)
Fig. 27 Chemistry market, 2018 - 2030 (USD Million)
Fig. 28 Medicinal chemistry market, 2018 - 2030 (USD Million)
Fig. 29 Computation chemistry market, 2018 - 2030 (USD Million)
Fig. 30 Safety pharmacology market, 2018 - 2030 (USD Million)
Fig. 31 Others market, 2018 - 2030 (USD Million)
Fig. 32 Preclinical CRO market model type outlook: Segment dashboard
Fig. 33 Preclinical CRO market: Model type movement analysis
Fig. 34 Patient derived organoid (PDO) models market, 2018 - 2030 (USD Million)
Fig. 35 Patient derived xenograft (PDX) models market, 2018 - 2030 (USD Million)
Fig. 36 Preclinical CRO market end-use outlook: Segment dashboard
Fig. 37 Preclinical CRO market: End-use movement analysis
Fig. 38 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 39 Government and academic institutes market, 2018 - 2030 (USD Million)
Fig. 40 Medical device companies market, 2018 - 2030 (USD Million)
Fig. 41 Regional market: Key takeaways
Fig. 42 Regional outlook, 2021 & 2030
Fig. 43 North America market, 2018 - 2030 (USD Million)
Fig. 44 U.S. market, 2018 - 2030 (USD Million)
Fig. 45 Canada market, 2018 - 2030 (USD Million)
Fig. 46 Europe market, 2018 - 2030 (USD Million)
Fig. 47 UK market, 2018 - 2030 (USD Million)
Fig. 48 Germany market, 2018 - 2030 (USD Million)
Fig. 49 France market, 2018 - 2030 (USD Million )
Fig. 50 Italy market, 2018 - 2030 (USD Million)
Fig. 51 Spain market, 2018 - 2030 (USD Million)
Fig. 52 Denmark market, 2018 - 2030 (USD Million)
Fig. 53 Sweden market, 2018 - 2030 (USD Million)
Fig. 54 Norway market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 56 Japan market, 2018 - 2030 (USD Million)
Fig. 57 China market, 2018 - 2030 (USD Million)
Fig. 58 India market, 2018 - 2030 (USD Million)
Fig. 59 Australia market, 2018 - 2030 (USD Million)
Fig. 60 Singapore market, 2018 - 2030 (USD Million)
Fig. 61 Philippines market, 2018 - 2030 (USD Million)
Fig. 62 Indonesia market, 2018 - 2030 (USD Million)
Fig. 63 Malaysia market, 2018 - 2030 (USD Million)
Fig. 64 Thailand market, 2018 - 2030 (USD Million)
Fig. 65 South Korea market, 2018 - 2030 (USD Million)
Fig. 66 Latin America market, 2018 - 2030 (USD Million)
Fig. 67 Brazil market, 2018 - 2030 (USD Million)
Fig. 68 Mexico market, 2018 - 2030 (USD Million)
Fig. 69 Argentina market, 2018 - 2030 (USD Million)
Fig. 70 MEA market, 2018 - 2030 (USD Million)
Fig. 71 South Africa market, 2018 - 2030 (USD Million)
Fig. 72 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 73 UAE market, 2018 - 2030 (USD Million)
Fig. 74 Kuwait Arabia market, 2018 - 2030 (USD Million)